SCHEMBL6414535

SCHEMBL6414535

CCNCCCCNCCCCNCCCCNCCCC(N(C(C(N)=O)(S(=O)(=O)c1c(C)cc(C)cc1C)S(=O)(=O)c1c(C)cc(C)cc1C)S(=O)(=O)c1c(C)cc(C)cc1C)S(=O)(=O)c1c(C)cc(C)cc1C

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6102029 0.73 FABP4 (0.30) FABP4
SCHEMBL4746886 0.72 NR3C1 (0.36) FABP4
SCHEMBL7940206 0.68 FABP4 (0.34) FABP4
SCHEMBL7937672 0.65 FABP4 (0.36) FABP4
SCHEMBL6094467 0.63 FABP4 (0.34) FABP4
SCHEMBL4265168 0.61 FABP4 (0.34) FABP4
SCHEMBL6413864 0.59 CA1 (0.39) FABP4
SCHEMBL7517197 0.59 FABP4 (0.34) FABP4
SCHEMBL4821971 0.58 F2 (0.43)
SCHEMBL4743600 0.56 F2 (0.41) FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515973-A1 PORPHYRIN-POLYAMINE CONJUGATES FOR CANCER THERAPY Cellgate Inc. (US) 2005-03-23 EP disclosed
WO-2004002991-A1 PORPHYRIN-POLYAMINE CONJUGATES FOR CANCER THERAPY CELLGATE, INC. (US) 2004-01-08 WO disclosed